[up] Up a level
Group by: Item Type | Date | No Grouping
Number of items: 2.

Bröckelmann, Paul J. ORCID: 0000-0001-9662-9900, Böll, Boris ORCID: 0000-0002-6432-0981, Molin, Daniel, Schneider, Gundolf ORCID: 0000-0001-6175-2554, Leppä, Sirpa ORCID: 0000-0002-8265-511X, Meissner, Julia, Kamper, Peter, Hutchings, Martin, Christensen, Jacob H., Schnetzke, Ulf, Fuchs, Michael ORCID: 0000-0003-3289-3272, Jablonski, Janina ORCID: 0009-0007-2811-4762, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, von Tresckow, Bastian ORCID: 0000-0003-1410-4487, Klapper, Wolfram ORCID: 0000-0001-7208-4117, Kobe, Carsten ORCID: 0000-0002-2909-0826, Borchmann, Peter ORCID: 0000-0003-3782-2158 and Fosså, Alexander ORCID: 0000-0002-4484-9319 (2025). Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced‐stage Hodgkin lymphoma in older patients. HemaSphere, 9 (8). pp. 1-5. Wiley. ISSN 2572-9241

Rosenbrock, Johannes ORCID: 0000-0003-3340-0556, Kaul, Helen, Oertel, Michael, Celik, Eren, Linde, Philipp ORCID: 0000-0002-2813-1331, Fan, Jiaqi, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Bröckelmann, Paul J. ORCID: 0000-0001-9662-9900, von Tresckow, Bastian ORCID: 0000-0003-1410-4487, Kobe, Carsten ORCID: 0000-0002-2909-0826, Dietlein, Markus ORCID: 0000-0003-0992-6099, Fuchs, Michael ORCID: 0000-0003-3289-3272, Borchmann, Peter ORCID: 0000-0003-3782-2158, Eich, Hans Theodor and Baues, Christian (2024). Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma—An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group. International journal of radiation oncology, biology, physics, 120 (5). pp. 1344-1352. Elsevier Science. ISSN 0360-3016

This list was generated on Wed May 13 21:23:17 2026 CEST.